FDAnews
www.fdanews.com/articles/141693-ancor-buys-wellspring-pharmaceutical

Ancor Buys WellSpring Pharmaceutical

November 11, 2011
Ancor Capital Partners acquired WellSpring Pharmaceutical. WellSpring, based in Sarasota, Fla., and in Toronto, is a manufacturer and marketer of specialty prescription and over-the-counter products, and offers contract manufacturing.
Tampa Bay Business Journal